As part of our series focussing on medicines available in Australia, we have added a product review of the use of sonidegib for the management of locally advanced and metastatic basal cell carcinoma.
This review discusses indications and dosage, contraindications and a series of clinical studies featuring sonidegib. It provides commentary from Clinical Associate Professor Alex Guminski, a medical oncologist at Royal North Shore Hospital, and the Mater Hospital, Sydney.
Please login below to download this issue (PDF)